Schonfeld Strategic Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.7M	Buy	1,337,693 +1,196,244	+846%	+$9.29M	0.1%	243
2025 Q4	$1.1M	Sell	141,449 -25,392	-15%	-$184K	0.01%	1092
2025 Q3	$1.27M	Sell	166,841 -586,143	-78%	-$4.88M	0.01%	1275
2025 Q2	$6.75M	Buy	752,984 +140,765	+23%	+$1.31M	0.05%	462
2025 Q1	$4.59M	Buy	612,219 +394,479	+181%	+$3.18M	0.03%	554
2024 Q4	$1.64M	Buy	217,740 +46,650	+27%	+$354K	0.01%	911
2024 Q3	$1.3M	Sell	171,090 -281,513	-62%	-$2.14M	0.01%	1067
2024 Q2	$2.8M	Buy	+452,603	New	+$2.5M	0.02%	761
2023 Q3	–	Sell	-121,137	Closed	-$853K	–	1787
2023 Q2	$853K	Buy	+121,137	New	+$972K	0.01%	1030
2023 Q1	–	Sell	-21,100	Closed	-$242K	–	2106
2022 Q4	$242K	Sell	21,100 -186,872	-90%	-$2.33M	﹤0.01%	1898
2022 Q3	$2.62M	Buy	207,972 +36,676	+21%	+$472K	0.02%	757
2022 Q2	$1.81M	Sell	171,296 -116,404	-40%	-$1.2M	0.02%	780
2022 Q1	$4.68M	Buy	287,700 +234,500	+441%	+$3.76M	0.05%	468
2021 Q4	$737K	Buy	53,200 +23,741	+81%	+$314K	0.01%	1084
2021 Q3	$423K	Sell	29,459 -75,628	-72%	-$1.19M	﹤0.01%	1352
2021 Q2	$1.66M	Buy	105,087 +85,383	+433%	+$1.16M	0.02%	774
2021 Q1	$201K	Sell	19,704 -67,687	-77%	-$698K	﹤0.01%	1504
2020 Q4	$650K	Sell	87,391 -154,020	-64%	-$794K	0.01%	955
2020 Q3	$830K	Buy	241,411 +74,183	+44%	+$318K	0.02%	753
2020 Q2	$797K	Buy	+167,228	New	+$668K	0.02%	675
2020 Q1	–	Sell	-397,266	Closed	-$1.37M	–	1152
2019 Q4	$1.37M	Sell	397,266 -514,034	-56%	-$1.29M	0.03%	419
2019 Q3	$2.61M	Sell	911,300 -1,322,400	-59%	-$4.11M	0.08%	265
2019 Q2	$8.47M	Buy	+2,233,700	New	+$13.4M	0.3%	83
2019 Q1	–	Sell	-11,000	Closed	-$89K	–	1046
2018 Q4	$89K	Sell	11,000 -43,800	-80%	-$341K	﹤0.01%	1009
2018 Q3	$418K	Buy	+54,800	New	+$368K	0.02%	612
2017 Q3	–	Sell	-13,723	Closed	-$76K	–	596
2017 Q2	$76K	Sell	13,723 -62,860	-82%	-$383K	0.01%	582
2017 Q1	$643K	Buy	+76,583	New	+$533K	0.06%	327